Although testing of FAT1 was impractical in our replication samples owing to moderate DNA quantity and the large size of the FAT1 gene, we performed in silico replication using publicly available data from 99 bladder cancers in the TCGA consortium. The gene discussed is FAT1; the disease is urinary bladder cancer.